| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000025617 |
| Receipt No. | R000029369 |
| Scientific Title | Effects of royal jelly on improvement of brain function |
| Date of disclosure of the study information | 2017/01/11 |
| Last modified on | 2019/07/20 (Ver. 13) |
| Basic information | ||
| Public title | Effects of royal jelly on improvement of brain function | |
| Acronym | Effects of royal jelly on improvement of brain function | |
| Scientific Title | Effects of royal jelly on improvement of brain function | |
| Scientific Title:Acronym | Effects of royal jelly on improvement of brain function | |
| Region |
|
|
| Condition | |||
| Condition | Psychiatric disorders | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To investigate effect of royal jelly on psychological state, neurophysiological function of the central nervous system, sleep quality and cognitive function, and biochemical changes related to the health status of the brain. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Survey 8 weeks after administration
Electroencephalography (event-related potential P3a & P3b, mismatch negativity, evoked gamma rhythms, and auditory evoked potentials) |
| Key secondary outcomes | Questionnaires (BDI, PANAS)
Evaluation of cognitive function (attention network test, word frequency test, digit symbol substitution test, verbal learning test, effort based decision making test) MRS (measurement of glutathione, NAA, NAAG, glutamate, glutamine) Biochemical analysis (sleep-wake cycle-related hormones, inflammatory factors, stress-related hormones) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test material: Dried royal jelly powder
Duration: 8 weeks Dose: Daily 1000mg (equivalent to 3000 mg of fresh Royal Jelly) |
|
| Interventions/Control_2 | Test material: Placebo
Duration: 8 weeks Dose: Casein 500mg, carbohydrate 90mg, lipid 24mg (equivalent amounts of protein, carbohydrate, and lipid contained in 3000 mg of royal jelly) |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Men and women aged 30 to 75 years old
(2) BMI of more than 25 |
|||
| Key exclusion criteria | (1) Those who are being treated for psychiatric or neurological diseases
(2) Those who are diagnosed metabolic syndrome and currently being treated (3) Those who currently have or previously had asthma (4) Those who currently have or previously had food allergies |
|||
| Target sample size | 60 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Hokkaido University Graduate School of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 060-8638 | ||||||
| Address | Kita-15 Nishi-7 Kita-ward Sapporo Hokkaido, Japan | ||||||
| TEL | 011-706-5160 | ||||||
| mkoga@med.hokudai.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Hokkaido University Graduate School of Medicine | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 060-8638 | ||||||
| Address | Kita-15 Nishi-7 Kita-ward Sapporo Hokkaido, Japan | ||||||
| TEL | 011-706-5160 | ||||||
| Homepage URL | |||||||
| mkoga@med.hokudai.ac.jp | |||||||
| Sponsor | |
| Institute | Hokkaido University
Department of Psychiatry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The JAPAN Royal Jelly Fair Trade Council |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | The Institutional Ethical Board for Epidemiological Studie |
| Address | Kita-15 Nishi-7 Kita-ward Sapporo Hokkaido, Japan |
| Tel | 011-706-5003 |
| shomu@med.hokudai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | YES |
| Study ID_1 | 16-013 |
| Org. issuing International ID_1 | The Institutional Ethical Board for Epidemiological Studies at Hokkaido University Graduate School of Medicine |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | ||
| URL related to results and publications | ||
| Number of participants that the trial has enrolled | 48 | |
| Results | ||
| Results date posted | ||
| Results Delayed |
|
|
| Results Delay Reason | Preparing for publication | |
| Date of the first journal publication of results | ||
| Baseline Characteristics | ||
| Participant flow | ||
| Adverse events | ||
| Outcome measures | ||
| Plan to share IPD | ||
| IPD sharing Plan description | ||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029369 |